版本:
中国

BRIEF-Ritter Pharma says on March 1, co held type C informational meeting with U.S. FDA

March 13 Ritter Pharmaceuticals Inc

* Ritter pharmaceuticals - on march 1, co held type c informational meeting with u.s. Fda to discuss development plans and its current clinical trial for treatment of lactose intolerance

* Focus of meeting was to gain feedback about company s statistical analysis plan

* Ritter pharma-to modify aspects of its sap, including modifying its primary endpoint to combine abdominal pain with relevant secondary endpoints to establish abdominal composite score Source text for Eikon: (bit.ly/2nh4dDp) Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐